ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 136 filers reported holding ANAPTYSBIO INC in Q3 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $42,316,000 | -38.0% | 1,209,378 | 0.0% | 0.01% | -37.5% |
| Q2 2019 | $68,233,000 | +7.5% | 1,209,378 | +39.2% | 0.02% | +6.7% |
| Q1 2019 | $63,444,000 | +14.5% | 868,500 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $55,402,000 | -29.2% | 868,500 | +10.7% | 0.02% | -21.1% |
| Q3 2018 | $78,270,000 | +184.7% | 784,500 | +102.7% | 0.02% | +216.7% |
| Q2 2018 | $27,492,000 | -13.1% | 387,000 | +27.3% | 0.01% | -14.3% |
| Q1 2018 | $31,640,000 | – | 304,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |